Pfizer-BioNTech begin Omicron vaccine trial: statement
WASHINGTON, United States (AFP) -- Pfizer and BioNTech have begun enrollment for a clinical trial to test the safety and…
3 years ago
Health
Covid outbreak on ship threatens Tonga aid efforts
NUKU'ALOFA, Tonga (AFP) - A Covid-19 outbreak on an Australian warship threatened to disrupt Tonga eruption aid efforts Tuesday, as…
3 years ago
Omicron ‘sub-variant’ throws up new virus questions
Latest Omicron subvariant dubbed BA.2 detected in Britain, 40 other countries including India, Denmark and Sweden by Isabelle TOURNÉ…
3 years ago
Antibiotic-resistant superbugs killed 1.2 mn in 2019: study
PARIS, France (AFP) -- Superbug infections killed 1.2 million people in 2019, according to a study published Thursday, which…
3 years ago
US Covid doc: We are ‘burned out’
by Joe Prezioso NEW YORK, United States (AFP) -- Exhausted and overwhelmed by the influx of mostly unvaccinated Covid patients,…
3 years ago
Natural immunity more potent than vaccines during US Delta wave: study
WASHINGTON, United States (AFP) -- During America's last surge of the coronavirus driven by the Delta variant, people who were…
3 years ago
Covid pandemic ‘nowhere near over’: WHO chief
GENEVA, Switzerland (AFP) -- The Covid-19 pandemic is far from over, the World Health Organization chief said Tuesday, cautioning against…
3 years ago
WHO approves two new Covid-19 treatments
PARIS, France (AFP) -- The World Health Organization approved two new Covid-19 treatments on Friday, growing the arsenal of tools…
3 years ago
Reduced hospitalization risk, shorter stays for Omicron patients: US study
WASHINGTON, United States (AFP) -- A preliminary US study of nearly 70,000 Covid positive people showed a substantially reduced risk…
3 years ago
Repeated Covid boosters not a viable strategy: WHO
by Nina LARSON GENEVA, Switzerland (AFP) -- WHO experts warned Tuesday that repeating booster doses of the original Covid vaccines…
3 years ago
This website uses cookies.